English
简体中文
Total: £ 56.28
Published Date: 2025-01-13 | Pages: 91 | Tables: 96 | Medical Care
The global market for Precision Medicine was valued at US$ 142800 million in the year 2024 and is projected to reach a revised size of US$ 268890 million by 2031, growing at a CAGR of 9.6% during the forecast period.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.
The Precision Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
Segment by Type
Diagnostics
Therapies
Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Market by Application
1.3.1 Global Precision Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Market Perspective (2020-2031)
2.2 Global Precision Medicine Growth Trends by Region
2.2.1 Global Precision Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Medicine Historic Market Size by Region (2020-2025)
2.2.3 Precision Medicine Forecasted Market Size by Region (2026-2031)
2.3 Precision Medicine Market Dynamics
2.3.1 Precision Medicine Industry Trends
2.3.2 Precision Medicine Market Drivers
2.3.3 Precision Medicine Market Challenges
2.3.4 Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Medicine Players by Revenue
3.1.1 Global Top Precision Medicine Players by Revenue (2020-2025)
3.1.2 Global Precision Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Medicine Revenue
3.4 Global Precision Medicine Market Concentration Ratio
3.4.1 Global Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Revenue in 2024
3.5 Global Key Players of Precision Medicine Head office and Area Served
3.6 Global Key Players of Precision Medicine, Product and Application
3.7 Global Key Players of Precision Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Medicine Breakdown Data by Type
4.1 Global Precision Medicine Historic Market Size by Type (2020-2025)
4.2 Global Precision Medicine Forecasted Market Size by Type (2026-2031)
5 Precision Medicine Breakdown Data by Application
5.1 Global Precision Medicine Historic Market Size by Application (2020-2025)
5.2 Global Precision Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Medicine Market Size (2020-2031)
6.2 North America Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Medicine Market Size by Country (2020-2025)
6.4 North America Precision Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Medicine Market Size (2020-2031)
7.2 Europe Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Medicine Market Size by Country (2020-2025)
7.4 Europe Precision Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Market Size (2020-2031)
8.2 Asia-Pacific Precision Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Medicine Market Size (2020-2031)
9.2 Latin America Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Medicine Market Size by Country (2020-2025)
9.4 Latin America Precision Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Market Size (2020-2031)
10.2 Middle East & Africa Precision Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Precision Medicine Introduction
11.1.4 Johnson & Johnson Revenue in Precision Medicine Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Precision Medicine Introduction
11.2.4 Roche Revenue in Precision Medicine Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Precision Medicine Introduction
11.3.4 Labcorp Revenue in Precision Medicine Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Precision Medicine Introduction
11.4.4 Abbott Laboratories Revenue in Precision Medicine Business (2020-2025)
11.4.5 Abbott Laboratories Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Precision Medicine Introduction
11.5.4 Novartis Revenue in Precision Medicine Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Precision Medicine Introduction
11.6.4 Illumina Revenue in Precision Medicine Business (2020-2025)
11.6.5 Illumina Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Precision Medicine Introduction
11.7.4 GE Healthcare Revenue in Precision Medicine Business (2020-2025)
11.7.5 GE Healthcare Recent Development
11.8 Intel Corporation
11.8.1 Intel Corporation Company Details
11.8.2 Intel Corporation Business Overview
11.8.3 Intel Corporation Precision Medicine Introduction
11.8.4 Intel Corporation Revenue in Precision Medicine Business (2020-2025)
11.8.5 Intel Corporation Recent Development
11.9 Biomrieux Sa
11.9.1 Biomrieux Sa Company Details
11.9.2 Biomrieux Sa Business Overview
11.9.3 Biomrieux Sa Precision Medicine Introduction
11.9.4 Biomrieux Sa Revenue in Precision Medicine Business (2020-2025)
11.9.5 Biomrieux Sa Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Precision Medicine Introduction
11.10.4 Cepheid Revenue in Precision Medicine Business (2020-2025)
11.10.5 Cepheid Recent Development
11.11 IBM
11.11.1 IBM Company Details
11.11.2 IBM Business Overview
11.11.3 IBM Precision Medicine Introduction
11.11.4 IBM Revenue in Precision Medicine Business (2020-2025)
11.11.5 IBM Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Precision Medicine Introduction
11.12.4 Qiagen Revenue in Precision Medicine Business (2020-2025)
11.12.5 Qiagen Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Precision Medicine Introduction
11.13.4 Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Randox Laboratories
11.14.1 Randox Laboratories Company Details
11.14.2 Randox Laboratories Business Overview
11.14.3 Randox Laboratories Precision Medicine Introduction
11.14.4 Randox Laboratories Revenue in Precision Medicine Business (2020-2025)
11.14.5 Randox Laboratories Recent Development
11.15 Almac Group
11.15.1 Almac Group Company Details
11.15.2 Almac Group Business Overview
11.15.3 Almac Group Precision Medicine Introduction
11.15.4 Almac Group Revenue in Precision Medicine Business (2020-2025)
11.15.5 Almac Group Recent Development
11.16 Healthcore
11.16.1 Healthcore Company Details
11.16.2 Healthcore Business Overview
11.16.3 Healthcore Precision Medicine Introduction
11.16.4 Healthcore Revenue in Precision Medicine Business (2020-2025)
11.16.5 Healthcore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Precision Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapies
Table 4. Global Precision Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Precision Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Precision Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Precision Medicine Market Share by Region (2020-2025)
Table 8. Global Precision Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Precision Medicine Market Share by Region (2026-2031)
Table 10. Precision Medicine Market Trends
Table 11. Precision Medicine Market Drivers
Table 12. Precision Medicine Market Challenges
Table 13. Precision Medicine Market Restraints
Table 14. Global Precision Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Precision Medicine Market Share by Players (2020-2025)
Table 16. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Table 17. Ranking of Global Top Precision Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Precision Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Precision Medicine, Headquarters and Area Served
Table 20. Global Key Players of Precision Medicine, Product and Application
Table 21. Global Key Players of Precision Medicine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Precision Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Precision Medicine Revenue Market Share by Type (2020-2025)
Table 25. Global Precision Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Precision Medicine Revenue Market Share by Type (2026-2031)
Table 27. Global Precision Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Precision Medicine Revenue Market Share by Application (2020-2025)
Table 29. Global Precision Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Precision Medicine Revenue Market Share by Application (2026-2031)
Table 31. North America Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Precision Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Precision Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Precision Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Precision Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Precision Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Precision Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson & Johnson Company Details
Table 47. Johnson & Johnson Business Overview
Table 48. Johnson & Johnson Precision Medicine Product
Table 49. Johnson & Johnson Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 50. Johnson & Johnson Recent Development
Table 51. Roche Company Details
Table 52. Roche Business Overview
Table 53. Roche Precision Medicine Product
Table 54. Roche Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Labcorp Company Details
Table 57. Labcorp Business Overview
Table 58. Labcorp Precision Medicine Product
Table 59. Labcorp Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 60. Labcorp Recent Development
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Precision Medicine Product
Table 64. Abbott Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Precision Medicine Product
Table 69. Novartis Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Illumina Company Details
Table 72. Illumina Business Overview
Table 73. Illumina Precision Medicine Product
Table 74. Illumina Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 75. Illumina Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Precision Medicine Product
Table 79. GE Healthcare Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. Intel Corporation Company Details
Table 82. Intel Corporation Business Overview
Table 83. Intel Corporation Precision Medicine Product
Table 84. Intel Corporation Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 85. Intel Corporation Recent Development
Table 86. Biomrieux Sa Company Details
Table 87. Biomrieux Sa Business Overview
Table 88. Biomrieux Sa Precision Medicine Product
Table 89. Biomrieux Sa Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 90. Biomrieux Sa Recent Development
Table 91. Cepheid Company Details
Table 92. Cepheid Business Overview
Table 93. Cepheid Precision Medicine Product
Table 94. Cepheid Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 95. Cepheid Recent Development
Table 96. IBM Company Details
Table 97. IBM Business Overview
Table 98. IBM Precision Medicine Product
Table 99. IBM Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 100. IBM Recent Development
Table 101. Qiagen Company Details
Table 102. Qiagen Business Overview
Table 103. Qiagen Precision Medicine Product
Table 104. Qiagen Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 105. Qiagen Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific Precision Medicine Product
Table 109. Thermo Fisher Scientific Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. Randox Laboratories Company Details
Table 112. Randox Laboratories Business Overview
Table 113. Randox Laboratories Precision Medicine Product
Table 114. Randox Laboratories Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 115. Randox Laboratories Recent Development
Table 116. Almac Group Company Details
Table 117. Almac Group Business Overview
Table 118. Almac Group Precision Medicine Product
Table 119. Almac Group Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 120. Almac Group Recent Development
Table 121. Healthcore Company Details
Table 122. Healthcore Business Overview
Table 123. Healthcore Precision Medicine Product
Table 124. Healthcore Revenue in Precision Medicine Business (2020-2025) & (US$ Million)
Table 125. Healthcore Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Precision Medicine Picture
Figure 2. Global Precision Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Precision Medicine Market Share by Type: 2024 VS 2031
Figure 4. Diagnostics Features
Figure 5. Therapies Features
Figure 6. Global Precision Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Precision Medicine Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Neurosciences Case Studies
Figure 10. Immunology Case Studies
Figure 11. Respiratory Case Studies
Figure 12. Others Case Studies
Figure 13. Precision Medicine Report Years Considered
Figure 14. Global Precision Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Precision Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Precision Medicine Market Share by Region: 2024 VS 2031
Figure 17. Global Precision Medicine Market Share by Players in 2024
Figure 18. Global Top Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Medicine as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Precision Medicine Revenue in 2024
Figure 20. North America Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Precision Medicine Market Share by Country (2020-2031)
Figure 22. United States Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Precision Medicine Market Share by Country (2020-2031)
Figure 26. Germany Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Precision Medicine Market Share by Region (2020-2031)
Figure 34. China Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Precision Medicine Market Share by Country (2020-2031)
Figure 42. Mexico Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Precision Medicine Market Share by Country (2020-2031)
Figure 46. Turkey Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Precision Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Johnson & Johnson Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 51. Labcorp Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 52. Abbott Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 54. Illumina Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 56. Intel Corporation Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 57. Biomrieux Sa Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 58. Cepheid Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 59. IBM Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 60. Qiagen Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 62. Randox Laboratories Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 63. Almac Group Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 64. Healthcore Revenue Growth Rate in Precision Medicine Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
